Keywords: drug-eluting balloon; in-stent restenosis; paclitaxel-coated balloon; percutaneous coronary intervention; target lesion failure; BSR; drug-eluting balloon-to-stent ratio; CI; confidence interval; DEB; drug-eluting balloon; DES; drug-eluting stent(s)
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: AmP; Add-my-Pet; DEB; dynamic energy budgets; EFSA; European Food Safety Authority; LD50; lethal dose for 50% of the individuals; LC50; lethal concentration for 50% of the individuals; NOEC; No Observed Effect Concentration; NEC; No Effect Concentration;
Keywords: AT-1; angiotensin II type 1; AT-2; angiotensin II type 2; BM; basement membrane; C/EBP3β; CCAAT/enhancer binding protein β; cSCC; cutaneous squamous cell carcinoma; EB; epidermolysis bullosa; ECM; extracellular matrix; DEB; dystrophic epidermolysis bull
Keywords: AO; adverse outcome; AOP; adverse outcome pathway; BMD; benchmark dose modelling; BQE; biological quality element; CA; concentration addition; CAG; cumulative assessment group; CMEP; chemical monitoring and emerging pollutants; CRA; cumulative risk assess
Keywords: EB; epidermolysis bullosa; BMZ; basement membrane zone; EBS; epidermolysis bullosa simplex; JEB; junctional epidermolysis bullosa; DEB; dystrophic epidermolysis bullosa; KS; kindler syndrome; DEJ; dermal-epidermal junction; PTC; premature termination codo
Keywords: Skin; TGFβ; Inflammation; Extracellular matrix; Therapy; ACE; angiotensin-converting enzyme; ACE2; angiotensin-converting enzyme 2; AT1; angiotensin II receptor type 1; ADAM; a disintegrin and metalloproteinase family sheddase; AT2; angiotensin II recept
Keywords: EB; epidermolysis bullosa; EBS; EB simplex; JEB; junctional EB; DEB; dystrophic EB; HD; hemidesmosome; LM-332; laminin-332; PTC; premature termination codon; ECM; extracellular matrix; Epidermolysis bullosa; Heritable blistering diseases; Basement membran
Keywords: EB; epidermolysis bullosa; EBS; epidermolysis bullosa simplex; JEB; junctional epidermolysis bullosa; DEB; dystrophic epidermolysis bullosa;
Keywords: ADFI; average daily feed intake; ADG; average daily gain; ATTD; apparent total tract digestibility; BW; body weight; dEB; dietary electrolyte balance; DM; dry matter; GE; gross energy; G:F; gain to feed ratio; mEq; milliequivalents; N; nitrogen; Dietary e
Keywords: AD; Alzheimer's dementia; DEB; dream-enactment behavior; DLB; dementia with Lewy bodies; IRBD; idiopathic random eye movement sleep behavior disorder; MCI; mild cognitive impairment; MCRF; medullary magnocellular reticular formation; MSA; multiple syste
Keywords: DEB; dream enactment behavior; DLB; dementia with Lewy bodies; NREM; non-rapid eye movement; OSA; obstructive sleep apnea; PD; Parkinson disease; PSG; polysomnography; RBD; rapid eye movement sleep behavior disorder; REM; rapid eye movement; SSRI; selec
Keywords: ALT; alanine aminotransferase; AST; aspartate aminotransferase; DEB; drug-eluting bead; LFT; liver function test; NET; neuroendocrine tumors;
Keywords: Size-at-age; Diversity; Land use; DEB; Umbra limi;
Keywords: AGP; antibiotic growth promotants; Aw; water activity; DEB; dietary electrolyte balance; FPD; footpad dermatitis; HCl; hydrochloric acid; NaHCO3; sodium bicarbonate; NE; necrotic enteritis; NSP; non-starch polysaccharides; FCR; Feed conversion ratio; Broi
Keywords: DEB; drug-eluting balloon; DES; drug-eluting stent; HDL; high-density lipoprotein; LDL; low-density lipoprotein; TC; total cholesterol; TG; triglycerides;
Keywords: DEB; drug-eluting bead; EHD; extrahepatic disease; HAE; hepatic artery embolization; HCC; hepatocellular carcinoma; HR; hazard ratio; LN; lymph node; OS; overall survival; PFS; progression-free survival; SHARP; Sorafenib HCC Assessment Randomized Protocol
Keywords: BCLC; Barcelona Clinic Liver Cancer; DEB; drug-eluting bead; HCC; hepatocellular carcinoma; MELD; Model for End-stage Liver Disease;
Keywords: ATP; adenosine-5â²-triphosphate; CI; chromosome instability; DEB; (±)-1,2:3,4-diepoxybutane; FA; Fanconi Anemia; FOM; fosfomycin; GSH; reduced glutathione; HD; healthy donors; ICL; interstrand crosslinks; IFAR; Fanconi Anemia Registry; MurA; enolpyruvyl
Xylene isomerization side reactions over Beta zeolite: Disproportionation and transalkylation of C8 aromatics and toluene
Keywords: Bz; benzene; DEB; diethylbenzene; EB; ethylbenzene; ET; ethyl-toluene; EX; ethyl-xylene; MX; m-xylene; MR; membered rings; OX; o-xylene; PX; p-xylene; SMBR; Simulated Moving Bed Reactor; SAR; silica alumina ratio; TOL; toluene; TMB; trimethylbenzene; Tolu
Collagen VII deficient mice show morphologic and histologic corneal changes that phenotypically mimic human dystrophic epidermolysis bullosa of the eye
Keywords: Collagen VII; Epidermolysis bullosa; DEB; RDEB; Cornea; Eye; Scarring; Opacity; Vision loss; Blindness; Mouse; Murine;
Beyond interstrand crosslinks repair: contribution of FANCD2 and other Fanconi Anemia proteins to the replication of DNA
Keywords: A-EJ; alternative end joing; APH; aphidicolin; BIR; break induced replication; BTRR; BLM helicase/topoisomerase IIIa (TOPOIIIa)/RMI1 and RMI2 cofactors; CFS; common fragile sites; Cis; cisplatin; DEB; diepoxybutane; DSBs; double strand breaks; DSEs; one e
Large Deletions Targeting the Triple-Helical Domain of Collagen VII Lead to Mild Acral Dominant Dystrophic Epidermolysis Bullosa
Keywords: AF; anchoring fibrils; C7; collagen VII; DEB; dystrophic epidermolysis bullosa;
The role of TGFβ in wound healing pathologies
Keywords: ECM; extracellular matrix; DEB; dystrophic epidermolysis bullosa; DEJZ; dermo-epidermal junction zone; LH3; lysyl hydroxylase 3; TGFβ; transforming growth factor beta; Recessive dystrophic epidermolysis bullosa; Cell adhesion; Collagen VII; Fibrosis;
EB2017-Progress in Epidermolysis Bullosa Research toward Treatment and Cure
Keywords: BMT; bone marrow transplantation; DEB; dystrophic epidermolysis bullosa; DEBRA; Dystrophic Epidermolysis Bullosa Research Association; EB; epidermolysis bullosa; EBS; epidermolysis bullosa simplex; JEB; junctional epidermolysis bullosa; PTC; premature ter
Polymerase bypass of N7-guanine monoadducts of cisplatin, diepoxybutane, and epichlorohydrin
Keywords: DEB; 1,2,3,4-diepoxybutane; ECH; epichlorohydrin; DPAGE; denaturing polyacrylamide gel electrophoresis; KF; DNA polymerase I, Klenow fragment from E. coli; BF; DNA polymerase I, large fragment from Bacillus stearothermophilus; hPol β; human polymerase be
Dietary electrolyte balance affects growth performance, amylase activity and metabolic response in the meagre (Argyrosomus regius)
Keywords: AMS; aerobic metabolic scope; BW; body weight; DEB; dietary electrolyte balance; DM; dry matter; FCR; feed conversion ratio; FI; feed intake; GE; gross energy; GEI; gross energy intake; GIT; gastro-intestinal tract; HSI; hepatosomatic index; MMR; maximal
A type VII collagen subdomain mutant is thermolabile and shows enhanced proteolytic degradability - Implications for the pathogenesis of recessive dystrophic epidermolysis bullosa?
Keywords: DEB; dystrophic epidermolysis bullosa; MMP9; matrix metalloproteinase 9; NC; non-collagenous domain; FNIII; fibronectin III like; Type VII collagen; Dystrophic epidermolysis bullosa; Protease cleavage;
Spectral and 3D model studies of the interaction of orphan human cytochrome P450 2U1 with substrates and ligands
Keywords: AA; arachidonic acid; AS; N-arachidonoylserotonin; BSA; bovine serum albumin; CYP; cytochrome P450; Deb; debrisoquine; DLPC; 1,2-Didodecanoyl-sn-glycero-3-phosphocholine; Im; imidazole; IPTG; isopropyl β-D-1-thiogalactopyranoside; LA; lauric acid; Terfim
ReviewCell therapy for basement membrane-linked diseases
Keywords: BM; basement membrane; BMT; bone marrow transplantation; EB; epidermolysis bullosa; DEB; dystrophic epidermolysis bullosa; HSCs; hematopoietic stem cells; iPSCs; induced pluripotent stem cells; JEB; junctional epidermal bullosa; MSCs; mesenchymal stromal
Kinetic and Mechanistic Study of the pH-Dependent Activation (Epoxidation) of Prodrug Treosulfan Including the Reaction Inhibition in a Borate Buffer
Keywords: chemical stability; complexation; HPLC; kinetics; prodrugs; B; boric acid (unionized); Bâ; borate anion; CB; total concentration of a borate buffer; CT; total concentration of T; DEB; (2S,3S)-1,2:3,4-diepoxybutane; EBDM; (2S,3S)-1,2-epoxybutane-3,4-diol
Dystrophic Epidermolysis Bullosa: COL7A1 Mutation Landscape in a Multi-Ethnic Cohort of 152 Extended Families with High Degree of Customary Consanguineous Marriages
Keywords: DEB; dystrophic epidermolysis bullosa; EB; epidermolysis bullosa; Mb; mega-base pair; NGS; next-generation sequencing; RDEB; recessive dystrophic EB; SNP; single nucleotide polymorphism; WES; whole-exome sequencing;
Pro-Inflammatory Chemokines and Cytokines Dominate the Blister Fluid Molecular Signature in Patients with Epidermolysis Bullosa and Affect Leukocyte and Stem Cell Migration
Keywords: ADSC; adipose-derived stem cell; BF; blister fluid; BMZ; basement membrane zone; DEB; dystrophic epidermolysis bullosa; EB; epidermolysis bullosa; EBS; epidermolysis bullosa simplex; JEB; junctional epidermolysis bullosa; MMP; matrix metalloproteinase; PB
Comparison of outcomes after treatment of in-stent restenosis using newer generation drug-eluting stents versus drug-eluting balloon: Patient-level pooled analysis of Korean Multicenter in-Stent Restenosis Registry
Keywords: ACS; acute coronary syndrome; ARC; Academic Research Consortium; BD-DES; biodurable polymer coated drug-eluting stent; BR-DES; bioresorbable polymer coated drug eluting stent; BMS; bare metal stent; CVA; cerebrovascular accidents; DEB; drug-eluting balloo
Epidermolysis Bullosa Acquisita Develops in Dominant Dystrophic Epidermolysis Bullosa
Keywords: COL7; collagen VII; DDEB; dominant dystrophic epidermolysis bullosa; DEB; dystrophic epidermolysis bullosa; DEJ; dermal-epidermal junction; EBA; epidermolysis bullosa acquisita; NC1; noncollagenous amino-terminal domain; RDEB; recessive dystrophic epiderm
Local Ultrasound to Enhance Paclitaxel Delivery After Femoral-Popliteal Treatment in Critical Limb Ischemia
Keywords: critical limb ischemia; femoral-popliteal artery disease; paclitaxel; ultrasound; BTK; below-the-knee; CLI; critical limb ischemia; DEB; drug-eluting balloon; DSA; digital subtraction angiography; DUS; duplex ultrasonography; FU; follow-up; MI; myocardial
Progress toward Treatment and Cure of Epidermolysis Bullosa: Summary of the DEBRA International Research Symposium EB2015
Keywords: BM; bone marrow; BMT; bone marrow transplantation; DEB; dystrophic EB; EB; epidermolysis bullosa; HMGB1; high mobility group box 1; iPSCs; inducible pluripotent stem cells; JEB; junctional EB; MSC; mesenchymal stromal/stem cell; RDEB; recessive DEB; SCC;
Original ArticleCell BiologyCollagen VII Half-Life at the Dermal-Epidermal Junction Zone: Implications for Mechanisms and Therapy of Genodermatoses
Keywords: DEJZ; dermal-epidermal junction zone; DEB; dystrophic epidermolysis bullosa; MSC; mesenchymal stromal cell;
Superselective Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma: Rationale, Technique, and Outcome
Keywords: CR; complete remission; DEB; drug-eluting bead; GS; gelatin sponge; HCC; hepatocellular carcinoma; PBP; peribiliary vascular plexus;
Preparation of Radiopaque Drug-Eluting Beads for Transcatheter Chemoembolization
Keywords: DEB; drug-eluting bead; microCT; micro-computed tomography; UHPLC; ultra-high-performance liquid chromatography;
A 2-year follow-up of a randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels the BELLO study
Keywords: BMS; bare-metal stent(s); DEB; drug-eluting balloon(s); DES; drug-eluting stent(s); ECG; electrocardiogram; ISR; in-stent restenosis; MACE; major adverse cardiac event; MI; myocardial infarction; PES; paclitaxel-eluting stents; RCT; randomized controlled
Transarterial Hepatic Chemoembolization with 70-150 µm Drug-Eluting Beads: Assessment of Clinical Safety and Liver Toxicity Profile
Keywords: AE; adverse event; DEB; drug-eluting bead; HCC; hepatocellular carcinoma; LBI; liver/biliary injuries; PES; postembolization syndrome;
Safety and Efficacy of 70-150 μm and 100-300 μm Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
Keywords: BCLC; Barcelona Clinic Liver Cancer; DEB; drug-eluting bead; DEE; drug-eluting embolic; HCC; hepatocellular carcinoma; mRECIST; modified Response Evaluation Criteria In Solid Tumors;
Biophysical characterization of the interaction between FAAP20-UBZ4 domain and Rev1-BRCT domain
Keywords: FA; Fanconi anemia; ICL; interstrand cross-link; DSB; double-strand break; HR; homologous recombination; MMC; mitomycin C; DEB; diepoxybutane; TLS; translesion synthesis; NER; nucleotide excision repair; FAAP20; Fanconi anemia-associated protein 20; UBZ4;
High throughput HPLC-ESIâ-MS/MS methodology for mercapturic acid metabolites of 1,3-butadiene: Biomarkers of exposure and bioactivation
Keywords: BD; 1,3-butadiene; EB; 3,4-epoxy-1-butene; HMVK; hydroxymethyl vinyl ketone; EBD; 3,4-epoxy-1,2-diol; DEB; 1,2,3,4-diepoxybutane; MHBMA; monohydroxybutenyl mercapturic acid; DHBMA; dihydroxybutyl mercapturic acid; THBMA; trihydroxybutyl mercapturic acid;
Baseline and Early MR Apparent Diffusion Coefficient Quantification as a Predictor of Response of Unresectable Hepatocellular Carcinoma to Doxorubicin Drug-Eluting Bead Chemoembolization
Keywords: ADC; apparent diffusion coefficient; AUC; area under the curve; CR; complete response; DEB; drug-eluting bead; DWI; diffusion-weighted imaging; EASL; European Association for the Study of the Liver; HCC; hepatocellular carcinoma; LRT; locoregional therapy
Expression in yeast, new substrates, and construction of a first 3D model of human orphan cytochrome P450 2U1: Interpretation of substrate hydroxylation regioselectivity from docking studies
Keywords: AA; arachidonic acid; a.m.u.; atomic mass unit; a.u.; arbitrary units; CYP; cytochrome P450; Deb; debrisoquine; 1- 3-, 4-, 5-, 6-, 7- and 8-OH-Deb; 1-, 3-, 4-, 5-, 6-, 7-, and 8-hydroxy-debrisoquine, respectively; N-OH-Deb; N-hydroxy-debrisoquine; Deb-ure
Meta-Analysis of Drug-Eluting Balloon Angioplasty and Drug-Eluting Stent Placement for Infrainguinal Peripheral Arterial Disease
Keywords: BMS; bare metal stent; DEB; drug-eluting balloon; DES; drug-eluting stent; GRADE; Grades of Recommendation Assessment, Development, and Evaluation; LLL; late lumen loss; OR; odds ratio; PAD; peripheral arterial disease; PTA; percutaneous transluminal angi
Reactions of H3PO4 forming polymers. Apparently simple reactions leading to sophisticated structures and applications
Keywords: D; diesters; DEB; diepoxybutane; DEPA; diethylphosphoric acid; DGEBA; diglicydyl ether of Bisphenol A; EG; ethylene glycol; EPA; ethylphosphoric acid; ERL; epoxycylohexylmethyl-3,4-epoxycyclohexanecarboxylate; G; glycerol; M; monoesters; PA; phosphoric ac
Can we reach consensus between marine ecological models and DEB theory? A look at primary producers
Keywords: DEB; ERSEM; Ecological modeling; Primary producers
A fully-spatial ecosystem-DEB model of oyster (Crassostrea virginica) carrying capacity in the Richibucto Estuary, Eastern Canada
Keywords: Aquaculture; Crassostrea virginica; DEB; Physical–biogeochemical model; Chlorophyll depletion; Carrying capacity